Andere Sprachen Getinge AB

Aktien

Realtime-Estimate Cboe Europe Andere Börsenplätze 16:48:04 29.04.2024			% 5 Tage	% 1. Jan.
239,8 ^SEK	+1,98 %		+3,59 %	+6,87 %

24.04.	GETINGE : Q1 24: Investoren blicken über den Umsatzrückgang hinaus
22.04.	Getinge AB (publ) erklärt eine Dividende, zahlbar am 29. April 2024	CI

GETINGE : Q1 24: Investors look beyond the top-line miss	24.04.
Nordic Stocks Closed Up Monday; Getinge Series B Climbed Highest	22.04.
Resolutions at Getinge's Annual General Meeting 22 April 2024	22.04.
Getinge AB Declares A Dividend, Payable on 29 April 2024	22.04.
Getinge : Presentation Q1 2024	22.04.
Medical gear maker Getinge's Q1 core profit beats expectations	22.04.
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value	22.04.
Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2024	22.04.
Getinge’s Covered Stent System Gets EU Medical Device Regulation Certification	11.04.
Getinge invites fund managers, analysts, and media to Q1 Report 2024 conference call	08.04.
GETINGE : EPS cut (2023: +3.1%, 2024: -10.5%)	04.04.
Getinge : Fluobeam LX Launch in Amman, Jordan	01.04.
Getinge : extends the bioreactor portfolio with larger single-use systems	28.03.
Lighting the Way to Excellence: Getinge's new innovative products launch	27.03.
Getinge : Corporate Governance Report 2023 (including Auditor’s Report)	27.03.
Getinge publishes 2023 annual report	27.03.
Getinge : and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing	25.03.
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)	15.03.
Getinge AB Announces Barbro Fridén Declines Re-Election from the Board	15.03.
Getinge AB Proposes Dividend, Payable on April 29, 2024	15.03.

Keine Ergebnisse zu dieser Suche

GETINGE : Q1 24: Investoren blicken über den Umsatzrückgang hinaus

Am 24. April 2024 um 08:06 Uhr